PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The protein survivin could be a useful biomarker for pancreatic cancer

2012-04-02
(Press-News.org) CHICAGO, IL (April 1, 2012)––Pancreatic cancer kills more than 40,000 people every year, and among cancers it's particularly insidious. For 80 percent of patients, the disease is already so advanced at the time of diagnosis that treatment is unlikely to provide significantly life-extending benefits. For patients diagnosed with localized pancreatic cancer, the five-year survival rate remains barely above 20 percent, according to the National Cancer Institute. New research from scientists at Fox Chase Cancer Center in Philadelphia, which will be presented at the AACR Annual Meeting 2012 on Sunday, April 1, shows that a protein called survivin could be a useful tool in understanding pancreatic cancer—particularly for identifying which subsets of patients will most likely respond to treatment.

In a recent study of pancreatic cancer patients who had undergone tumor resection, the scientists found that patients who underwent different treatment regimens, following surgery, had different levels of survivin and experienced different lengths of disease-free survival.

"Biomarkers for pancreatic cancer are especially useful because the survival is so poor and it's such a bad disease for people to get," says Saad Khan, M.D., a medical oncology fellow at Fox Chase. "We're looking for biomarkers that tell us how the cancer will behave, whether or not it's a more aggressive type that will spread to different parts of the body. Most importantly for our research, we want to see if there are drugs that work better in patients with survivin than in those who don't have it."

They first studied cancerous tissues from 88 patients who had had pancreatic tumors, as well as nearby lymph nodes, surgically removed at Fox Chase. The researchers found higher levels of survivin in the cells from the lymph nodes than in the cells from the primary tumor. They went on to measure survivin in cells from 60 patients, of the original 88, who had undergone chemotherapy or radiation after surgery. The patients with higher levels of survivin lived longer periods of time before the cancer returned. The connection was strongest and statistically significant in patients who received the chemotherapy drug gemcitabine, though the researchers found similarly suggestive trends among patients who received radiation therapy or 5-FU.

"We found that when there was a higher amount of survivin expressed in the nucleus, there was significantly longer disease-free survival for all patients," says Khan. "In terms of overall survival, patients treated with chemotherapy or radiation did better when they had higher amounts of survivin which goes against what we'd expected, but this did not achieve statistical significance. Our results suggest that people with higher levels of survivin responded better to specific chemotherapies."

Survivin—which is readily detectable in cancerous and embryonic tissues but not in most healthy tissue—is a protein that blocks apoptosis, or cell death. Because of its strong association with cancer, researchers have long sought ways to use survivin to better understand and treat the disease.

"Survivin has been looked at quite carefully in many cancers," Khan says, "but there's been no clear information about how it is expressed in a large number of pancreatic cells."

Khan, finishing up his third year of medical oncology training, came up with the idea to study survivin with his mentor, Barbara A. Burtness, M.D., associate director for clinical research and professor of medical oncology at Fox Chase. The researchers used a surgical specimens linked to a patient database prepared by coauthor and surgical oncologist John P. Hoffmann, M.D.

It's too early to know how useful survivin will be as a prognostic indicator. Khan says the next step is to study more pancreatic cancer samples and try to understand all the different variables that can impact a person's survival. The researchers have also started studying survivin in other tumor samples, including those from patients treated for head and neck cancers.

"There's a lot of work being done in biomarkers for more aggressive cancers, like pancreatic," Khan says. "We are hoping to find ways to improve on existing chemotherapies, which are ineffective for controlling disease for a significant period of time,"

###

In addition to Khan, Burtness and Hoffman, the Fox Chase coauthors include Donghua Yang, M.D., Fang Zhu, Cara Dubyk, Mohamed Tejani, M.D. (currently assistant professor at Wilmot Cancer Center, University of Rochester), and Steven J. Cohen, M.D., chief of gastrointestinal oncology. The work was supported by funds from the Marvin S. Greenberg, M.D., Chair in Pancreatic Cancer Surgery.

Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).

END



ELSE PRESS RELEASES FROM THIS DATE:

Fox Chase scientists identify key protein players in hard-to-treat breast cancers

2012-04-02
CHICAGO, IL (April 1, 2012)––At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells. Over time, however, the disease often becomes resistant to estrogen deprivation from the drugs—making treatment options more limited. New findings that will be ...

New comparison of ocean temperatures reveals rise over the last century

2012-04-02
A new study contrasting ocean temperature readings of the 1870s with temperatures of the modern seas reveals an upward trend of global ocean warming spanning at least 100 years. The research led by Scripps Institution of Oceanography at UC San Diego physical oceanographer Dean Roemmich shows a .33-degree Celsius (.59-degree Fahrenheit) average increase in the upper portions of the ocean to 700 meters (2,300 feet) depth. The increase was largest at the ocean surface, .59-degree Celsius (1.1-degree Fahrenheit), decreasing to .12-degree Celsius (.22-degree Fahrenheit) at ...

Raising the school leaving – while learning from another age

2012-04-02
In April 1947 the post-war Labour Government raised the school leaving age from 14 to 15 and paved the way for a further increase to 16 in 1972. Now, 65 years later, as the UK prepares to raise the 'education participation age' to 17 in 2013 and to 18 in 2015, new research reveals that the transitions of 1947 and 1972 met with more controversy and difficulty than previously thought. In a study funded by the Economic and Social Research Council, Dr Tom Woodin and Professor Gary McCulloch of the Institute of Education, London, analysed the debate surrounding the implementation ...

Expert task force recommends halving global fishing for crucial prey species

Expert task force recommends halving global fishing for crucial prey species
2012-04-02
WASHINGTON – Fishing for herring, anchovy, and other "forage fish" in general should be cut in half globally to account for their critical role as food for larger species, recommends an expert group of marine scientists in a report released today. The Lenfest Forage Fish Task Force conducted the most comprehensive worldwide analysis of the science and management of forage fish populations to date. Its report, "Little Fish, Big Impact: Managing a crucial link in ocean food webs," concluded that in most ecosystems at least twice as many of these species should be left in ...

New discovery may lead to effective prevention and treatment of graft-versus-host dsease

2012-04-02
Bethesda, MD -- A new discovery in mice may lead to new treatments that could make bone marrow transplants more likely to succeed and to be significantly less dangerous. According to new research findings published in the Journal of Leukocyte Biology (https://www.jleukbio.org) Brazilian scientists may have found a way to prevent the immune system from attacking transplant grafts and damaging the host's own cells after a bone marrow transplant. Specifically, they found that a receptor for a mediator of the inflammatory process, known as platelet activating factor plays ...

Gene variations linked to intestinal blockage in newborns with cystic fibrosis

Gene variations linked to intestinal blockage in newborns with cystic fibrosis
2012-04-02
CHAPEL HILL, N.C. -- University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium have discovered several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage while still in the uterus. A report of this international study appears online April 1, 2012 in the journal Nature Genetics. It was the work of the North America CF Gene Modifier Consortium, which brought together dozens of investigators from the United States, Canada, and from France, to identify genetic ...

Picky females promote diversity: UBC-IIASA study

2012-04-02
Picky females play a critical role in the survival and diversity of species, according to a Nature study by researchers from the University of British Columbia and the International Institute for Applied Systems Analysis (IIASA) in Austria. To date, biodiversity theories have focused on the role played by adaptations to the environment: the species best equipped to cope with a habitat would win out, while others would gradually go extinct. The new study presents the first theoretical model demonstrating that selective mating alone can promote the long-term coexistence ...

DNA sequencing lays foundation for personalized cancer treatment

DNA sequencing lays foundation for personalized cancer treatment
2012-04-02
Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor – considered key to personalizing cancer treatment – but to map the genetic evolution of disease and monitor response to treatment. "We're finding clinically relevant information in the tumor samples we're sequencing for discovery-oriented research studies," says Elaine Mardis, PhD, co-director of The Genome Institute at the School of Medicine. "Genome analysis can play a role at multiple time ...

Los Angeles Personal Injury Lawyer, Farhad Hamdam, is Now Offering Representation for All Personal Injury Cases Involving Car Accidents

Los Angeles Personal Injury Lawyer, Farhad Hamdam, is Now Offering Representation for All Personal Injury Cases Involving Car Accidents
2012-04-02
Minor accidents take place every single day in Southern California. These ordeals can often be resolved with the assistance of an insurance company and a fair settlement that is going to quickly pay for injuries, damage to property, or any other associated costs. When drivers are not receiving the financial assistance that they need in order to pay for serious or ongoing medical expenses though, it will not take much for the situation to enhance into a messy legal situation. In order to assist victims, the leading Los Angeles personal injury lawyer, Farhad Hamdam, is now ...

Epigenetic changes in twins of dieting mothers increases risk of obesity and diabetes

2012-04-02
Bethesda, MD—If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal (http://www.fasebj.org) suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives. This study provides exciting insights into how behavior can lead to epigenetic changes in offspring related to obesity and disease. "This study may provide a new understanding of why twins can ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] The protein survivin could be a useful biomarker for pancreatic cancer